ESTA Establishment Labs: Operating Margin

Corporate emblem and logo of Establishment Labs Inc (ESTA)

The ambitious management of Establishment Labs (ESTA) has ensured confident global development. The historical operating margin reflects current trends, where the parameter has stabilized at -6.60. Growth prospects rely on the implementation of the Mia system, FDA approval, and expansion into the US. Additional potential is created by unique patents for biocompatible surfaces, which allow the company to effectively displace traditional players in the aesthetic surgery segment.

ESTA: Establishment Labs Holdings Inc. Operating Margin 07/04/2022 - 11/19/2026

Establishment Labs - analytical breakdowns and key metrics (ESTA)

- share price and consensus valuation forecast:
Fundamental company analysis:ESTA, Establishment Labs Corp
Brand item of Establishment Labs Inc

Long-term investment success depends on the ability to distinguish market noise from actual business efficiency. Stable demand for Motiva implants provides Establishment Labs (ESTA) with a reliable cash flow, maintaining operational momentum. By analyzing the profitability of core operations, an investor can see the operating profit margin relative to total revenue. This metric excludes the impact of taxes and debt loads, exposing the quality of cost management. The growing trend confirms the high efficiency of the business model.

Competitors of Establishment Labs (ESTA)

BSX (Boston Scientific Corporation Inc.) - Operating Margin|Operating Margin Edwards Lifesciences Inc.|Operating Margin RMD|Operating Sales Margin Insulet Corporation PODD|Operating Profitability Zimmer Biomet ZBH|CooperVision - Operating Profitability|ALGN - Operating Profitability|GMED: Operating Profitability|TMDX (TransMedics Corp) - Operating Sales Margin|Alphatec Holdings, Inc. - Operating Profit Rate|AORT (Artivion Corp) - Operating Margin|Operating Return on Sales Enovis Corp ENOV|Operating Profitability Integra LifeSciences Corp (IART)|Beta Bionics Inc (BBNX) - Operating Profitability Margin|IRADIMED Inc. - Operating Sales Margin|Operating Margin Embecta Corp. EMBC|Tandem Diabetes Care Inc - Operating Margin|Profitability of Operations AxoGen Inc AXGN|SI-BONE (SIBN) - Operating Profitability|Operating Profit Margin OFIX (Orthofix Corp)|BVS (Bioventus Inc) - Operating Margin|Operating Sales Margin OrthoPediatrics Corp. (KIDS)|Operating Margin TMCI|SRTA - Operating Return on Sales|Operating Profitability Carlsmed Inc CARL|RXST: Return on Sales by Operating Profit|CLPT: Operating Sales Margin|stereotaxis.com - Operating Profit Ratio|NeuroStar (STIM) - Operating Profitability|SGHT - Profitability of Operations|Operating Profitability Orchestra BioMed|Return on Sales by Operating Profit ANIK (Anika Therapeutics)|Operating Profitability inspiremd.com (NSPR)|Jin Medical International Ltd - Return on Sales by Operating Profit|Operating Margin VANI (Vivani Medical Inc)|XTNT: Return on Sales by Operating Profit|NMTC - Operating Profitability|MODD: Operating Profitability|MYO: Operating Margin|envoymedical.com - Operating Profit Rate|Operating Sales Margin VVOS|Operating Return on Sales enVVeno NVNO|Operating Margin SINT|TNON - Operating Return on Sales|Operating Profitability ReWalk Robotics LFWD|AMIX: Return on Sales by Operating Profit|IVF - Operating Profitability|Operating Return on Sales Bone Biologics Corp|AXNX: Operating Margin|Operating Sales Margin BIOLASE, Inc.|Operating Sales Margin DYNT|Operating Sales Margin Paragon 28 (FNA)|Operating Profitability INVO Bio (INVO)